Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Anal Canal × nimotuzumab × Clear all

NCT01382745 2013-01-28

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Phase 2 Terminated

Gastrointestinal

Squamous Cell Carcinoma of Anal Canal